Vivione Biosciences Inc. announced the termination of Ted Moskal as President of Vivione and its operating subsidiary, Vivione Biosciences, LLC. Day-to-day responsibilities with the FDA will be assumed by Chief Medical Officer, Dr. Matthew Gombrich.
1st Jan change | Capi. | |
---|---|---|
+17.22% | 3.12B | |
+12.82% | 1.77B | |
+14.18% | 1.58B | |
-13.85% | 1.21B | |
+20.32% | 818M | |
+10.17% | 671M | |
+29.82% | 552M | |
-4.17% | 506M | |
+33.23% | 486M |